Ulrika Morris


AuthID: R-00G-A5B

Confirmed Publications: 3



1
TITLE: An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria
AUTHORS: Pernaute Lau, Leyre; Camara, Mahamadou; de Sousa, Tais Nobrega; Morris, Ulrika ; Ferreira, Marcelo Urbano; Gil, Jose Pedro;
PUBLISHED: 2022, SOURCE: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, VOLUME: 18, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 7
2
TITLE: Influence of cytochrome P450 (CYP) 2C8 polymorphisms on the efficacy and tolerability of artesunate-amodiaquine treatment of uncomplicated Plasmodium falciparum malaria in Zanzibar  Full Text
AUTHORS: Pernaute Lau, L; Morris, U ; Msellem, M; Martensson, A; Bjorkman, A; Gil, JP;
PUBLISHED: 2021, SOURCE: MALARIA JOURNAL, VOLUME: 20, ISSUE: 1
INDEXED IN: Scopus WOS
3
TITLE: Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018-2019
AUTHORS: Khan, AQ; Khan, AQ; Pernaute Lau, L; Pernaute Lau, L; Khattak, AA; Luijcx, S; Aydin Schmidt, B; Hussain, M; Khan, TA; Mufti, FU; Morris, U ;
PUBLISHED: 2020, SOURCE: MALARIA JOURNAL, VOLUME: 19, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 11
IN MY: ORCID

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service